Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genmab Sells Manufacturing Facility to Baxter | Contract Pharma

What are you searching for?

Sign in
Breaking News

Genmab Sells Manufacturing Facility to Baxter

Baxter acquires facility, land, and equipment in Brooklyn Park, MN

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genmab has signed an agreement with Baxter Healthcare Corp. for the sale of its non-plasma-derived antibody manufacturing facility in Brooklyn Park, MN, for $10 million. Baxter acquires the facility, land, and equipment at the site, and will offer employment to the 23 employees currently supporting the facility.
 
“We have delivered on our commitment to execute the sale of the antibody manufacturing facility in the first quarter of this year and are very pleased that Baxter acquired the facility, including the 23 employees who have maintained the facility to such a high standard,” said Jan van de Winkel, Ph.D., chief executive officer of Genmab.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics